BlackRock Japan
VNDA icon

BlackRock Japan’s Vanda Pharmaceuticals VNDA Stock Holding History

BlackRock Japan’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$22K Hold
1,395
– – ﹤0.01% 1107
2016
Q3 		$23K Sell
1,395
-360
-21% -$4.85K ﹤0.01% 1103
2016
Q2 		$20K Buy
+1,755
New +$17K ﹤0.01% 1163
2014
Q1 		– Sell
-924
Closed -$11K – 1459
2013
Q4 		$11K Buy
+924
New +$9.28K ﹤0.01% 1272

Other funds holding VNDA

PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Japan's VNDA Position: Q4 2016 in Review

BlackRock Japan held its Vanda Pharmaceuticals (VNDA) position steady in Q4 2016 at 1,395 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #1107.

BlackRock Japan first reported a position in VNDA in Q4 2013 and has held it in 4 quarters since. The position peaked at $23K in Q3 2016. 141 funds tracked by Wall St. Rank hold VNDA as of Q4 2016.

  • BlackRock Japan held 1,395 shares of Vanda Pharmaceuticals worth $22K as of Q4 2016.
  • BlackRock Japan left its Vanda Pharmaceuticals share count unchanged in Q4 2016.
  • Vanda Pharmaceuticals made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1107 holding.
  • BlackRock Japan first reported a position in Vanda Pharmaceuticals in Q4 2013 and has held it in 4 quarters since.
  • BlackRock Japan's Vanda Pharmaceuticals position peaked at $23K in Q3 2016.
  • 141 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.